ISTA PHARMACEUTICALS INC Increase (Decrease) in Other Operating Liabilities
ISTA PHARMACEUTICALS INC reported Increase (Decrease) in Other Operating Liabilities of $4.12 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for the quarter ending 2012-03-31 was $4.12M.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for the quarter ending 2011-12-31 was $31.00K, a 99.53% decline year-over-year.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for the quarter ending 2011-09-30 was -$482.00K, a 123.85% decline year-over-year.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for the quarter ending 2011-06-30 was -$2.36M.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for fiscal 2011 was -$5.03M, a 145.78% decline from fiscal 2010.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for fiscal 2010 was $10.99M, a 915.71% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC increase (decrease) in other operating liabilities for fiscal 2009 was $1.08M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2012-03-31 | $4.12M 10-Q · filed 2012-05-04 | $4.15M derived: sum of 2 quarters · filed 2012-05-04 | $3.67M derived: sum of 3 quarters · filed 2012-05-04 | $1.31M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$451.00K derived: sum of 2 quarters · filed 2012-02-27 | -$2.81M derived: sum of 3 quarters · filed 2012-02-27 | -$5.03M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$2.84M derived: sum of 2 quarters · filed 2011-11-07 | -$5.06M 10-Q · filed 2011-11-07 | $1.56M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | -$2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | -$4.58M 10-Q · filed 2011-08-01 | $2.04M derived: sum of 3 quarters · filed 2012-05-04 | $4.07M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | -$2.22M 10-Q · filed 2012-05-04 | $4.40M derived: sum of 2 quarters · filed 2012-05-04 | $6.42M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $8.64M derived: sum of 2 quarters · filed 2012-02-27 | $10.99M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $4.37M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $2.35M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $1.08M 10-K · filed 2012-02-27 |